Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.48 USD | +1.64% | -0.80% | -0.80% |
04-25 | OncoCyte Corporation announced that it has received $15.8 million in funding | CI |
04-16 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
Sales 2024 * | 1.45M 116M | Sales 2025 * | 5.9M 471M | Capitalization | 33.11M 2.64B |
---|---|---|---|---|---|
Net income 2024 * | -22M -1.76B | Net income 2025 * | -20M -1.6B | EV / Sales 2024 * | 22.8 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.61 x |
P/E ratio 2024 * |
-1.04
x | P/E ratio 2025 * |
-1.25
x | Employees | 45 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.36% |
Latest transcript on OncoCyte Corporation
1 day | +1.64% | ||
1 week | -0.80% | ||
Current month | -15.36% | ||
1 month | -15.36% | ||
3 months | -20.77% | ||
6 months | +8.77% | ||
Current year | -0.80% |
Managers | Title | Age | Since |
---|---|---|---|
Joshua Riggs
CEO | Chief Executive Officer | 42 | 31/07/20 |
James Liu
DFI | Director of Finance/CFO | 29 | 30/06/21 |
Yuh-Min Chiang
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Last
BRD | Director/Board Member | 64 | 22/12/15 |
Alfred Kingsley
BRD | Director/Board Member | 81 | 31/08/09 |
Louis Silverman
BRD | Director/Board Member | 65 | 29/11/22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 2.48 | +1.64% | 17,697 |
25/04/24 | 2.44 | -0.81% | 26,490 |
24/04/24 | 2.46 | +0.20% | 40,610 |
23/04/24 | 2.455 | -2.19% | 22,837 |
22/04/24 | 2.51 | +0.40% | 63,036 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.80% | 33.11M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.73% | 22.15B | |
-17.37% | 21.02B | |
-8.42% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- OCX Stock